We are live on ! Find out more
Canada Life

Canada Life Portfolio holdings

AUM $55.8B
1-Year Est. Return 26.04%
This Fund
S&P 500
This Quarter Est. Return
+12.79%
1 Year Est. Return
+26.04%
3 Year Est. Return
+87.85%
5 Year Est. Return
+117.08%
10 Year Est. Return
+382.61%
AUM
$45.5B
AUM Growth
+$3.87B
Cap. Flow
-$3.11B
Cap. Flow %
-6.83%
Top 10 Hldgs %
22.97%
Holding
2,251
New
17
Increased
879
Reduced
1,035
Closed
90

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$59.4M
2
AMZN icon
Amazon
AMZN
+$52.3M
3
CRH icon
CRH
CRH
+$29.3M
4
KVUE icon
Kenvue
KVUE
+$28.9M
5
MA icon
Mastercard
MA
+$27.4M

Top Sells

Rank Stock Value
1
TSM icon
TSMC
TSM
+$968M
2
NTES icon
NetEase
NTES
+$689M
3
RYAAY icon
Ryanair
RYAAY
+$518M
4
PDD icon
Pinduoduo
PDD
+$419M
5
ATVI
Activision Blizzard
ATVI
+$59.1M

Sector Composition

Rank Sector Weight
1 Technology 28.06%
2 Financials 12.85%
3 Healthcare 12.76%
4 Consumer Discretionary 11.54%
5 Communication Services 7.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HIFS icon
2151
Hingham Institution for Saving
HIFS
$663M
$11K ﹤0.01%
60
– –
OFLX icon
2152
Omega Flex
OFLX
$312M
$11K ﹤0.01%
159
– –
STOK icon
2153
Stoke Therapeutics
STOK
$2.11B
$11K ﹤0.01%
2,110
-858
-29% -$3.67K
ANGI icon
2154
Angi Inc
ANGI
$196M
$10K ﹤0.01%
389
– –
ITOS
2155
DELISTED
iTeos Therapeutics
ITOS
$9K ﹤0.01%
785
-20,610
-96% -$204K
PGEN icon
2156
Precigen
PGEN
$2.59B
$8K ﹤0.01%
6,020
-6,369
-51% -$7.48K
EPD icon
2157
Enterprise Products Partners
EPD
$81.7B
$3K ﹤0.01%
+102
New +$2.72K
ACRS icon
2158
Aclaris Therapeutics
ACRS
$869M
$2K ﹤0.01%
1,944
– –
BRT
2159
BRT Apartments
BRT
$271M
$2K ﹤0.01%
111
-10
-8% -$177
MPLX icon
2160
MPLX
MPLX
$59.7B
$2K ﹤0.01%
+46
New +$1.65K
BMTX
2161
DELISTED
BM Technologies, Inc.
BMTX
$1K ﹤0.01%
286
– –
ALCO icon
2162
Alico
ALCO
$283M
– –
-414
Closed -$10K
ALLK
2163
DELISTED
Allakos
ALLK
– –
-3,221
Closed -$7K
ANIK icon
2164
Anika Therapeutics
ANIK
$287M
– –
-2,962
Closed -$55K
ANGO icon
2165
AngioDynamics
ANGO
$649M
– –
-1,890
Closed -$14K
ARQT icon
2166
Arcutis Biotherapeutics
ARQT
$3.18B
– –
-2,159
Closed -$11K
ATLO icon
2167
AMES National
ATLO
$277M
– –
-443
Closed -$7K
AVD icon
2168
American Vanguard Corp
AVD
$68.9M
– –
-23,648
Closed -$259K
AXGN icon
2169
Axogen
AXGN
$2.5B
– –
-9,826
Closed -$49K
BAND
2170
Bandwidth Inc
BAND
$1.61B
– –
-1,287
Closed -$15K
BCBP icon
2171
BCB Bancorp
BCBP
$161M
– –
-1,120
Closed -$12K
BEPC icon
2172
Brookfield Renewable
BEPC
$6.26B
– –
-128,487
Closed -$3.08M
BG icon
2173
Bunge Global
BG
$20.8B
– –
-172,174
Closed -$18.6M
BGFV
2174
DELISTED
Big 5 Sporting Goods
BGFV
– –
-1,551
Closed -$11K
BLNK icon
2175
Blink Charging
BLNK
$87.9M
– –
-1,832,019
Closed -$5.59M
85 86
87
88 89

Similar funds

Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
Bank of Nova Scotia
Bank of Nova Scotia Toronto, Ontario, Canada $57.2B AUM 35.3% 1-Year Est. Return
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors Raleigh, North Carolina $57.3B AUM 18.32% 1-Year Est. Return
Capstone Investment Advisors
Capstone Investment Advisors New York $57.4B AUM 26.91% 1-Year Est. Return
Cohen & Steers
Cohen & Steers New York $57.6B AUM 8.03% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return

Canada Life's Q4 2023 Portfolio in Review

As of Q4 2023, Canada Life held 2,251 positions worth $45.5B, up 9.3% from $41.7B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Canada Life withdrew a net $3.11B in Q4 2023, closing 90 positions and reducing 1,035 holdings. Its most notable exit was Activision Blizzard, an estimated $59.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 27% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Canada Life opened a new position in Jazz Pharmaceuticals worth $9.89M.

  • Canada Life's largest Q4 2023 buy was Jazz Pharmaceuticals: 80,654 shares worth $9.89M.
  • Canada Life added most to AbbVie in Q4 2023, an estimated $59.4M increase.
  • Canada Life's biggest Q4 2023 reduction was TSMC, cutting an estimated $968M.
  • Canada Life fully exited Activision Blizzard in Q4 2023, selling an estimated $59.1M.
  • Canada Life's ten largest holdings make up 23% of its $45.5B portfolio in Q4 2023.
  • Canada Life opened 17 new positions and closed 90 in Q4 2023.
  • Canada Life's portfolio value rose 9.3% quarter-over-quarter to $45.5B.

Based on Canada Life's 13F filing for Q4 2023, filed 13 Feb 2024.